These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24305515)
1. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung. Stefani A; Franceschetto A; Nesci J; Aramini B; Proli C; Kaleci S; Casolo A; Massi L; Casali C; Morandi U J Cardiothorac Surg; 2013 Dec; 8():223. PubMed ID: 24305515 [TBL] [Abstract][Full Text] [Related]
2. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours. Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005 [TBL] [Abstract][Full Text] [Related]
3. Differential diagnostic value of Zhao J; Wang H Acad Radiol; 2022 Feb; 29 Suppl 2():S41-S46. PubMed ID: 33183953 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids. Jindal T; Kumar A; Venkitaraman B; Meena M; Kumar R; Malhotra A; Dutta R Cancer Imaging; 2011 Jun; 11(1):70-5. PubMed ID: 21697027 [TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas. Uhlén N; Grundberg O; Jacobsson H; Sundin A; Dobra K; Sánchez-Crespo A; Axelsson R; Kölbeck KG Clin Nucl Med; 2016 Apr; 41(4):263-7. PubMed ID: 26828139 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings. Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007 [TBL] [Abstract][Full Text] [Related]
7. Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids. Jindal T; Kumar A; Venkitaraman B; Dutta R; Kumar R Korean J Intern Med; 2010 Dec; 25(4):386-91. PubMed ID: 21179276 [TBL] [Abstract][Full Text] [Related]
8. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584 [TBL] [Abstract][Full Text] [Related]
9. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman. Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351 [TBL] [Abstract][Full Text] [Related]
10. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid. Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773 [TBL] [Abstract][Full Text] [Related]
11. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT). Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and differentiation of bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar components with metabolic and anatomic characteristics using PET/CT. Goudarzi B; Jacene HA; Wahl RL J Nucl Med; 2008 Oct; 49(10):1585-92. PubMed ID: 18794276 [TBL] [Abstract][Full Text] [Related]